GlobalData Market Research Reports
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge.
|
![]() |
List of reports from GlobalData
Displaying 401 to 430 (of 10431 records)
|
Ethylene Industry Outlook in Korea to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Feb 2013
Ethylene Industry Outlook in Korea to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Ethylene Industry Outlook in Korea to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of Korea Ethylene industry. The research presents major...
|
$1000 |
|
Ethylene Industry Outlook in the US to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Feb 2013
Ethylene Industry Outlook in the US to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Ethylene Industry Outlook in the US to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of The US Ethylene industry. The research presents...
|
$1000 |
|
Ethylene Industry Outlook in Russia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Feb 2013
Ethylene Industry Outlook in Russia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Ethylene Industry Outlook in Russia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of Russia Ethylene industry. The research presents...
|
$1000 |
|
Propylene Industry Outlook in China to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Feb 2013
Propylene Industry Outlook in China to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Propylene Industry Outlook in China to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of China Propylene industry. The research presents...
|
$1000 |
|
Propylene Industry Outlook in Saudi Arabia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants
Feb 2013
Propylene Industry Outlook in Saudi Arabia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalDatas report, Propylene Industry Outlook in Saudi Arabia to 2017 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants provides an in-depth coverage of Saudi Arabia Propylene industry. The...
|
$1000 |
|
Unconventional Gas (Gas Shales and Coal Bed Methane) - Global Market Analysis, Industry Developments, Investment Scenario and Forecasts to 2020
Feb 2013
Unconventional Gas (Gas Shales and Coal Bed Methane) - Global Market Analysis, Industry Developments, Investment Scenario and Forecasts to 2020 Summary Unconventional Gas (Gas Shales and Coal Bed Methane) - Global Market Analysis, Industry Developments, Investment Scenario and Forecasts to 2020 is the latest report from GlobalData, the industry analysis specialist, and analyzes the...
|
$3995 |
|
Oil & Gas Monthly Deals Analysis January 2013: M&A and Investment Trends
Feb 2013
Oil & Gas Monthly Deals Analysis January 2013: M&A and Investment Trends Summary GlobalData's Oil & Gas Monthly Deals Analysis January 2013: M&A and Investment Trends report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the oil and gas industry. The report provides detailed information on M&As,...
|
$1000 |
|
Refining Industry Outlook in Europe, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017
Feb 2013
Refining Industry Outlook in Europe, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017 Summary GlobalDatas energy offering, Refining Industry Outlook in Europe, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017 is the essential source for industry data and information relating to the refining...
|
$5000 |
|
Refining Industry Outlook in South and Central America, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017
Feb 2013
Refining Industry Outlook in South and Central America, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017 Summary GlobalDatas energy offering, Refining Industry Outlook in South and Central America, 2013 - Capacity Analysis, Forecasts and Details of All Operating and Planned Refineries to 2017 is the essential source for industry data and...
|
$5000 |
|
Healthcare, Regulatory and Reimbursement Landscape - Egypt
Feb 2013
Healthcare, Regulatory and Reimbursement Landscape - Egypt Summary GlobalData, the industry analysis specialist, has released its new report, Healthcare, Regulatory and Reimbursement Landscape - Egypt. The report is an essential source of information and analysis on Egypts healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides...
|
$1995 |
|
Healthcare, Regulatory and Reimbursement Landscape - Colombia
Feb 2013
Healthcare, Regulatory and Reimbursement Landscape - Colombia Summary Industry analysis specialist GlobalData has released its new report, Healthcare, Regulatory and Reimbursement Landscape - Colombia. An essential source of information and analysis on the Colombian healthcare, regulatory, and reimbursement landscape, this report identifies the key trends in the healthcare market, and...
|
$1995 |
|
Healthcare, Regulatory and Reimbursement Landscape - Switzerland
Feb 2013
Healthcare, Regulatory and Reimbursement Landscape - Switzerland Summary GlobalData, the industry analysis specialist, has released its new report, Healthcare, Regulatory and Reimbursement Landscape - Switzerland. The report is an essential source of information and analysis regarding the healthcare, regulatory, and reimbursement landscape in Switzerland.
It identifies key...
|
$1995 |
|
PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022
Feb 2013
PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - US Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction....
|
$4995 |
|
PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022
Feb 2013
PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - France Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
|
$4995 |
|
PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022
Feb 2013
PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - Germany Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
|
$4995 |
|
PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022
Feb 2013
PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - Italy Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
|
$4995 |
|
PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022
Feb 2013
PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - Spain Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
|
$4995 |
|
PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022
Feb 2013
PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - UK Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction....
|
$4995 |
|
PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022
Feb 2013
PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - Japan Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
|
$4995 |
|
PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022
Feb 2013
PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - India Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
|
$4995 |
|
PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022
Feb 2013
PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, PharmaPoint: Epilepsy - China Drug Forecast and Market Analysis to 2022. Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure...
|
$4995 |
|
Bronchiectasis Global Clinical Trials Review, H1, 2013
Feb 2013
Bronchiectasis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, Bronchiectasis Global Clinical Trials Review, H1, 2013" provides data on the Bronchiectasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bronchiectasis. It includes an overview of the trial numbers and...
|
$2500 |
|
Fabry Disease Global Clinical Trials Review, H1, 2013
Feb 2013
Fabry Disease Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, Fabry Disease Global Clinical Trials Review, H1, 2013" provides data on the Fabry Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fabry Disease. It includes an overview of the trial numbers and their...
|
$2500 |
|
Regurgitation Global Clinical Trials Review, H1, 2013
Feb 2013
Regurgitation Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, Regurgitation Global Clinical Trials Review, H1, 2013" provides data on the Regurgitation clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Regurgitation. It includes an overview of the trial numbers and...
|
$2500 |
|
Thromboembolism Global Clinical Trials Review, H1, 2013
Feb 2013
Thromboembolism Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, Thromboembolism Global Clinical Trials Review, H1, 2013" provides data on the Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thromboembolism. It includes an overview of the trial numbers...
|
$2500 |
|
Venous Thromboembolism Global Clinical Trials Review, H1, 2013
Feb 2013
Venous Thromboembolism Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, Venous Thromboembolism Global Clinical Trials Review, H1, 2013" provides data on the Venous Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Venous Thromboembolism . It includes an...
|
$2500 |
|
Ventricular Tachycardia Global Clinical Trials Review, H1, 2013
Feb 2013
Ventricular Tachycardia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, Ventricular Tachycardia Global Clinical Trials Review, H1, 2013" provides data on the Ventricular Tachycardia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ventricular Tachycardia. It includes...
|
$2500 |
|
Endotoxemia Global Clinical Trials Review, H1, 2013
Feb 2013
Endotoxemia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, Endotoxemia Global Clinical Trials Review, H1, 2013" provides data on the Endotoxemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Endotoxemia. It includes an overview of the trial numbers and their...
|
$2500 |
|
Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013
Feb 2013
Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, Diabetic Gastroparesis Global Clinical Trials Review, H1, 2013" provides data on the Diabetic Gastroparesis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Gastroparesis. It includes an...
|
$2500 |
|
Hypoxemia Global Clinical Trials Review, H1, 2013
Feb 2013
Hypoxemia Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, Hypoxemia Global Clinical Trials Review, H1, 2013" provides data on the Hypoxemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hypoxemia. It includes an overview of the trial numbers and their recruitment...
|
$2500 |
Displaying 401 to 430 (of 10431 records)
Research Assistance
Please call us or write us:
Email: sales@researchmoz.com
Main Category
Popular Reports
- Asia Pacific Renewable Energy Policy Handbook 2012
- Research Report on China's Polyester Industry Chain, 2013-2017
- Plastic Additives Market - Global Industry Analysis, Size, Share, Growth And Forecast, 2011 - 2016
- PC and Online Gaming Industry in India 2012
- Computed Radiography and Digital Radiography Market in Europe 2011-2015
- Home Healthcare Market - Global Industry Size, Market Share, Trends, Analysis And Forecast, 2012 - 2018
- Building Integrated Photovoltaics Markets 2012
- Gaming Market - Global Industry Analysis, Size, Growth, Share & Forecast, 2011 - 2015
- Water Treatment Chemicals And Technology Market - Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2011 - 2018
- Synthetic And Bio-Based Biodegradable Plastics - Global Industry Analysis, Market Size, Applications, Share, Growth And Forecast, 2011 - 2018







